Stay updated on ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial

Sign up to get notified when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A new revision, v3.6.6, was added to the study history, replacing the previous v3.6.5 and indicating the record has been updated. This reflects a metadata update to the page rather than a change to the study results.
    Difference
    0.1%
    Check dated 2026-08-30T21:55:18.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 is added to the Record History and the previous revision v3.6.4 is removed, indicating an updated release/history entry for the study page.
    Difference
    0.1%
    Check dated 2026-08-09T11:04:31.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.6.4 now appears in the record history, replacing Revision: v3.6.3.
    Difference
    0.1%
    Check dated 2026-07-25T22:58:52.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    A new revision entry v3.6.3 was added to the study record history, and the previous revision v3.6.2 was removed.
    Difference
    0.1%
    Check dated 2026-07-04T13:09:05.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry for v3.6.2. The previous v3.6.0 entry has been removed.
    Difference
    0.1%
    Check dated 2026-06-27T06:30:25.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    The study record history shows Vojtech Melenovsky, MD, PhD listed as the responsible party, adds 'Last verified' and 'Last known status' details, and records a new Revision: v3.6.0; older entries including 'Last known status was:', 'Verified', and Revision: v3.5.5 are removed.
    Difference
    3%
    Check dated 2026-06-13T01:09:20.000Z thumbnail image

Stay in the know with updates to ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.